Equivalence of basal insulin glargine vs prandial insulin lispro for glucose control in type 2 diabetes patients on oral agents - Results of the APOLLO study

被引：0
|
作者：
Bretzel, Reinhard G.
Linn, Thomas
机构：
来源：
DIABETES | 2006年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：A76 / A76
页数：1
相关论文
共 50 条
  • [1] Equivalence of basal insulin glargine versus prandial insulin lispro for glucose control in type 2 diabetes patients on oral agents - results of the APOLLO study
    Bretzel, R. G.
    Nuber, U.
    El-Haschimi, K.
    Linn, T.
    DIABETOLOGIA, 2006, 49 : 93 - 93
  • [2] Basal insulin glargine vs prandial insulin lispro in type 2 diabetes
    Arnolds, Sabine
    Rave, Klaus
    LANCET, 2008, 372 (9636): : 370 - 371
  • [3] Basal insulin glargine vs prandial insulin lispro in type 2 diabetes -: Reply
    Linn, Thomas
    Landgraf, W.
    Bretzel, Reinhard G.
    LANCET, 2008, 372 (9636): : 372 - 372
  • [4] Advancing insulin therapy in type 2 diabetes previously treated with glargine plus oral agents: Prandial premixed (Lispro/ILPS) vs basal/bolus (Glargine/Lispro) therapy
    Ahmann, A. J.
    Rosenstock, J.
    Colon, G.
    Scism-Bacon, J.
    Jiang, H. H.
    Martin, S.
    DIABETOLOGIA, 2007, 50 : S410 - S410
  • [5] Advancing insulin therapy in type 2 diabetes previously treated with glargine plus oral agents - Prandial premixed (insulin lispro protamine suspension/lispro) versus basal/bolus (glargine/lispro) therapy
    Rosenstock, Julio
    Scism-Bacon, Jamie
    Ahmann, Andrew J.
    Jiang, Honghua
    Colon, Gildred
    Martin, Sherry
    DIABETES CARE, 2008, 31 (01) : 20 - 25
  • [6] Intensive insulin therapy in type 2 diabetes (T2D) patients previously treated with glargine plus oral agents: Prandial NPL/lispro mixtures vs glargine/lispro basal/bolus
    Rosenstock, Julio
    Ahmann, Andrew J.
    Colon, Gildred
    Scism-Bacon, Jamie L.
    Jiang, Honghua H.
    Martin, Sherry
    DIABETES, 2007, 56 : A51 - A51
  • [7] Prandial insulin substitution with insulin lispro or insulin lispro, mid mixture vs. basal therapy with insulin glargine:: A randomized controlled trial in patients with type 2 diabetes beginning insulin therapy
    Kazda, C
    Hülstrunk, H
    Helsberg, K
    Langer, F
    Forst, T
    Hanefeld, M
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2006, 20 (03) : 145 - 152
  • [8] Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial
    Bretzel, Reinhard G.
    Nuber, Ulrike
    Landgraf, Wolfgang
    Owens, David R.
    Bradley, Clare
    Linn, Thomas
    LANCET, 2008, 371 (9618): : 1073 - 1084
  • [9] A comparison of prandial premixed (ILPS/lispro) vs basal bolus (glargine/lispro) insulin therapy in obese patients with type 2 diabetes (T2D)
    Ahmann, Andrew
    Jiang, Honghua
    Martin, Sherry A.
    DIABETES, 2008, 57 : A564 - A564
  • [10] Basal/bolus with prandial inhaled Technosphere insulin plus insulin glargine vs biaspart 70/30 insulin in type 2 diabetes inadequately controlled on insulin with/without oral agents
    Gnudi, L.
    Lorber, D.
    Rosenstock, J.
    Howard, C.
    Petrucci, R.
    Shearer, D.
    Bilheimer, D.
    Chang, P. -C.
    Richardson, P.
    DIABETOLOGIA, 2009, 52 : S360 - S360
12345